Skip to main content

Table 3 Prevalence of youth substance use prior to index admission

From: The CAMP study: feasibility and clinical correlates of standardized assessments of substance use in a youth psychiatric inpatient sample

Substance Time period or type of use Total sample (n = 100)
Alcohol Lifetime 73% (64 to 82)
Past 3 months 51% (41 to 61)
HED past month 29% (20 to 38)
AUDIT 8–15 “risky”a 17 (33% [20 to 46])
AUDIT ≥ 16 “harmful and high risk”a 6 (12% [3 to 21])
Cannabis Lifetime 66% (57 to 75)
Past 3 months 50% (40 to 60)
Daily past month 18% (10 to 26)
CUDIT 8–11 “hazardous”a 5 (10% [2 to 18])
CUDIT ≥ 12 “possible CUD”a 27 (54% [40 to 68])
Tobacco Lifetime 47% (37 to 57)
Past 3 months 33% (24 to 42)
Daily past month 14% (7 to 21)
E-cigarettes Lifetime 42% (32 to 52)
Past 3 months 34% (25 to 43)
Daily past month 14% (7 to 21)
Prescription opioids Lifetime 22% (14 to 30)
Past 3 months 18% (10 to 26)
Sedatives Lifetime 22% (14 to 30)
Past 3 months 14% (7 t 21)
Prescription stimulants Lifetime 21% (13 to 29)
Past 3 months 11% (5 to 17)
Cocaine Lifetime 18% (10 to 26)
Past 3 months 8% (3 to 13)
Hallucinogens Lifetime 22% (14 to 30)
Past 3 months 14% (7 to 21)
Solvents Lifetime 10% (4 to 16)
Past 3 months 4% (0 to 8)
Any prescription drug Lifetime 35% (26 to 44)
Past 3 months 24% (16 to 32)
Any illicit substance use Lifetime 34% (25 to 43)
Past 3 months 17% (10 to 24)
Any substance use Lifetime 79% (71 to 87)
Past 3 months 69% (60 to 78)
  1. Methamphetamines, street opioids, steroids, and synthetic cannabinoids were not included uniquely as prevalence was < 4%
  2. aFor those who endorsed use in the 3 months prior to index visit